Associate Professor James Bell

Bell J; Reed KD; Ashcroft R; Witton J; Strang J, 2012, 'Chapter 3 Treating Opioid Dependence with Opioids Exploring the Ethics', in Addiction Neuroethics, Elsevier, pp. 57 - 74, http://dx.doi.org/10.1016/b978-0-12-385973-0.00003-x

Bell J; Reed KD; Ashcroft R; Witton J; Strang J, 2012, 'Treating opioid dependence with opioids: Exploring the ethics', in Addiction Neuroethics: The ethics of addiction neuroscience research and treatment, pp. 57 - 74, http://dx.doi.org/10.1016/B978-0-12-385973-0.00003-X

Bell J; Reed KD; Ashcroft R; Witton J; Strang J, 2011, 'Treating Opioid Dependence with Opioids: Exploring the Ethics', in Addiction Neuroethics: The Ethics of Addiction Neuroscience Research and Treatment, pp. 57 - 74, http://dx.doi.org/10.1016/B978-0-12-385973-0.00003-X

Bell J, 2022, 'What are the considerations in the pharmacological management of opioid addiction in adolescents?', Expert Opinion on Pharmacotherapy, vol. 23, pp. 155 - 157, http://dx.doi.org/10.1080/14656566.2021.1998456

Nielsen S; Sanfilippo P; Belackova V; Day C; Silins E; Lintzeris N; Bruno R; Grebely J; Lancaster K; Ali R; Bell J; Dietze P; Degenhardt L; Farrell M; Larance B, 2021, 'Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: findings from a cross-sectional study in three Australian cities', Addiction, vol. 116, pp. 1482 - 1494, http://dx.doi.org/10.1111/add.15297

Bell J; Strang J, 2020, 'Medication Treatment of Opioid Use Disorder', Biological Psychiatry, vol. 87, pp. 82 - 88, http://dx.doi.org/10.1016/j.biopsych.2019.06.020

Tas B; Jolley CJ; Kalk NJ; van der Waal R; Bell J; Strang J, 2020, 'Heroin-induced respiratory depression and the influence of dose variation: within-subject between-session changes following dose reduction', Addiction, vol. 115, pp. 1954 - 1959, http://dx.doi.org/10.1111/add.15014

Belackova V; Salmon AM; Jauncey M; Bell J, 2019, 'Learning from the past, looking to the future - Is there a place for injectable opioid treatment among Australia's responses to opioid misuse?', International Journal of Drug Policy, vol. 71, pp. 164 - 168, http://dx.doi.org/10.1016/j.drugpo.2019.01.026

Bell J; Belackova V; Lintzeris N, 2018, 'Supervised Injectable Opioid Treatment for the Management of Opioid Dependence', Drugs, vol. 78, pp. 1339 - 1352, http://dx.doi.org/10.1007/s40265-018-0962-y

Reed K; Knight A; Baillie S; Bogdanowicz K; Bell J; Strang J, 2018, 'Switching between lyophilized and sub-lingual buprenorphine formulations in opioid-dependent patients: Observations on medication transfer during a safety and pharmacokinetic study', Heroin Addiction and Related Clinical Problems, vol. 20, pp. 19 - 28

Strang J; Knight A; Baillie S; Reed K; Bogdanowicz K; Bell J, 2018, 'Norbuprenorphine and respiratory depression: Exploratory analyses with new lyophilized buprenorphine and sublingual buprenorphine', International Journal of Clinical Pharmacology and Therapeutics, vol. 56, pp. 81 - 85, http://dx.doi.org/10.5414/CP203118

Bell J, 2017, 'Commentary on Nikoo et al. (2017): The role of research', Addiction, vol. 112, pp. 430 - 431, http://dx.doi.org/10.1111/add.13704

Bell J; Waal RVD; Strang J, 2017, 'Supervised Injectable Heroin: A Clinical Perspective', Canadian Journal of Psychiatry, vol. 62, pp. 451 - 456, http://dx.doi.org/10.1177/0706743716673966

Strang J; Reed K; Bogdanowicz K; Bell J; Van Der Waal R; Keen J; Beavan P; Baillie S; Knight A, 2017, 'Randomised Comparison of a Novel Buprenorphine Oral Lyophilisate versus Existing Buprenorphine Sublingual Tablets in Opioid-Dependent Patients: A First-in-Patient Phase II Randomised Open Label Safety Study', European Addiction Research, vol. 23, pp. 61 - 70, http://dx.doi.org/10.1159/000456612

Bell J, 2016, 'Alcohol use disorders', Medicine (United Kingdom), vol. 44, pp. 697 - 700, http://dx.doi.org/10.1016/j.mpmed.2016.09.001

Jolley CJ; Bell J; Rafferty GF; Moxham J; Strang J, 2015, 'S50 Understanding Heroin Overdose: A Study of the Acute Respiratory Depressant Effects of Injected Pharmaceutical Heroin', Thorax, vol. 70, pp. A31.2 - A32, http://dx.doi.org/10.1136/thoraxjnl-2015-207770.56

Jolley CJ; Bell J; Rafferty GF; Moxham J; Strang J, 2015, 'Understanding heroin overdose: A study of the acute respiratory depressant effects of injected pharmaceutical heroin', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0140995

Lee CH; Wang TJ; Tang HP; Liu YH; Bell J, 2015, 'Familial expressed emotion among heroin addicts in methadone maintenance treatment: Does it matter?', Addictive Behaviors, vol. 45, pp. 39 - 44, http://dx.doi.org/10.1016/j.addbeh.2015.01.014

Strang J; Groshkova T; Uchtenhagen A; Van Den Brink W; Haasen C; Schechter MT; Lintzeris N; Bell J; Pirona A; Oviedo-Joekes E; Simon R; Metrebian N, 2015, 'Heroin on trial: Systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction', British Journal of Psychiatry, vol. 207, pp. 5 - 14, http://dx.doi.org/10.1192/bjp.bp.114.149195

van Amsterdam J; Phillips L; Henderson G; Bell J; Bowden-Jones O; Hammersley R; Ramsey J; Taylor P; Dale-Perera A; Melichar J; van den Brink W; Nutt D, 2015, 'Ranking the harm of non-medically used prescription opioids in the UK', Regulatory Toxicology and Pharmacology, vol. 73, pp. 999 - 1004, http://dx.doi.org/10.1016/j.yrtph.2015.09.014

Bell J, 2014, 'Addiction and recovery', BMJ (Online), vol. 349, http://dx.doi.org/10.1136/bmj.g6880

Bell J, 2014, 'Pharmacological maintenance treatments of opiate addiction', British Journal of Clinical Pharmacology, vol. 77, pp. 253 - 263, http://dx.doi.org/10.1111/bcp.12051

Winstock AR; Borschmann R; Bell J, 2014, 'The non-medical use of tramadol in the UK: Findings from a large community sample', International Journal of Clinical Practice, vol. 68, pp. 1147 - 1151, http://dx.doi.org/10.1111/ijcp.12429

Bell J, 2013, 'Commentary on Krupitsky etal.(2013): Refuge from the streets-parked on methadone, or seeking shelter of a depot?', Addiction, vol. 108, pp. 1638 - 1639, http://dx.doi.org/10.1111/add.12248

Bell J; Healey C; Kennedy F; Faizal M; Shah AJ, 2013, 'Evidence and recovery; improving outcomes in opiate substitution treatment', British Journal of Medical Practitioners, vol. 6

Bell J; Kilic C; Prabakaran R; Wang YY; Wilson R; Broadbent M; Kumar A; Curtis V, 2013, 'Use of electronic health records in identifying drug and alcohol misuse among psychiatric in-patients', Psychiatrist, vol. 37, pp. 15 - 20, http://dx.doi.org/10.1192/pb.bp.111.038240

Winstock A; Bell J; Borschmann R, 2013, 'Friends, doctors, and tramadol: We might have a problem', BMJ (Online), vol. 347, http://dx.doi.org/10.1136/bmj.f5599

Bell J, 2012, 'Alcohol use disorders', Medicine (United Kingdom), vol. 40, pp. 637 - 639, http://dx.doi.org/10.1016/j.mpmed.2012.09.008

Bell J, 2012, 'Buprenorphine in the treatment of heroin addiction', Dusunen Adam - The Journal of Psychiatry and Neurological Sciences, vol. 25, pp. 93 - 100, http://dx.doi.org/10.5350/DAJPN20122502001

Bell J; Bowler S; Lyons J, 2012, 'Emergency care. Urgent issues of alcohol overload.', The Health service journal, vol. 122, pp. 26 - 27

Bell J, 2011, 'Commentary on Reimer etal. (2011): More work needed', Addiction, vol. 106, pp. 1656 - 1657, http://dx.doi.org/10.1111/j.1360-0443.2011.03557.x

Bell J, 2011, 'Your guide to today's mental health issues. Managing drug problems.', Mental health today (Brighton, England), pp. 25 - 27, https://www.ncbi.nlm.nih.gov/pubmed/21485445

Bell J; Collins R, 2011, 'Gamma-butyrolactone (GBL) dependence and withdrawal', Addiction, vol. 106, pp. 442 - 447, http://dx.doi.org/10.1111/j.1360-0443.2010.03145.x

Dean A; Saunders JB; Bell JR, 2011, 'Heroin use, dependence, and attitudes to treatment in non-treatment-seeking heroin users: a pilot study', Substance Use and Misuse, vol. 46, pp. 417 - 425, http://dx.doi.org/10.3109/10826084.2010.501655

Larance B; Degenhardt L; O'Brien S; Lintzeris N; Winstock A; Mattick RP; Bell J; Ali R, 2011, 'Prescribers' perceptions of the diversion and injection of medication by opioid substitution treatment patients', Drug and Alcohol Review, vol. 30, pp. 613 - 620, http://dx.doi.org/10.1111/j.1465-3362.2010.00274.x

Webzell I; Ball D; Bell J; Sherwood RA; Marsh A; O'Grady JG; Heaton ND, 2011, 'Substance use by liver transplant candidates: An anonymous urinalysis study', Liver Transplantation, vol. 17, pp. 1200 - 1204, http://dx.doi.org/10.1002/lt.22370

Bell J, 2010, 'Culture, treatment and the culture of treatment', Addiction, vol. 105, pp. 16 - 17, http://dx.doi.org/10.1111/j.1360-0443.2009.02771.x

Bell J, 2010, 'The global diversion of pharmaceutical drugs: Opiate treatment and the diversion of pharmaceutical opiates: A clinician's perspective', Addiction, vol. 105, pp. 1531 - 1537, http://dx.doi.org/10.1111/j.1360-0443.2010.03014.x

Shearer J; Mammen K; BELL J, 2010, 'The acceptability of combined methadone-naloxone treatment: Consumer and provider views on the potential utility of methadone-naloxone', Drug and Alcohol Review, vol. 29, pp. 138 - 143, http://dx.doi.org/10.1111/j.1465-3362.2009.00118.x

Bell J; Shearer J; Ryan A; Graham R; Korompay K; Rizzo S; Sindhusake D; Somogyi AA, 2009, 'The Acceptability, Safety, and Tolerability of Methadone/Naloxone in a 50: 1 Ratio', Experimental and Clinical Psychopharmacology, vol. 17, pp. 146 - 153, http://dx.doi.org/10.1037/a0016302

Bell JR; Trinh L; Butler B; Randall D; Rubin GL, 2009, 'Comparing retention in treatment and mortality inpeople after initial entry to methadone andbuprenorphine treatment', Addiction, vol. 104, pp. 1193 - 1200, http://dx.doi.org/10.1111/j.1360-0443.2009.02627.x

Mammen K; Bell J, 2009, 'The clinical efficacy and abuse potential of combination buprenorphine-naloxone in the treatment of opioid dependence', Expert Opinion on Pharmacotherapy, vol. 10, pp. 2537 - 2544, http://dx.doi.org/10.1517/14656560903213405

White J; Bell J; Saunders JB; Williamson P; Makowska M; Farquharson A; Beebe KL, 2009, 'Open-label dose-finding trial of buprenorphine implants (Probuphine)^® for treatment of heroin dependence', Drug and Alcohol Dependence, vol. 103, pp. 37 - 43, http://dx.doi.org/10.1016/j.drugalcdep.2009.03.008

Bell J; Butler B, 2008, 'Health care utilization and morbidity associated with methadone and buprenorphine treatment', Heroin Addiction and Related Clinical Problems, vol. 10, pp. 21 - 26

Bell J; Harvey-Dodds L, 2008, 'Pregnancy and injecting drug use', BMJ, vol. 336, pp. 1303 - 1305, http://dx.doi.org/10.1136/bmj.39514.554375.AE

Bell JR, 2008, 'Speciality recognition of addiction medicine in Australia', Addiction, vol. 103, pp. 701 - 702, http://dx.doi.org/10.1111/j.1360-0443.2007.02121.x

Bell JR; Ryan A; Mutch C; Batey RG; Rea F, 2008, 'Optimising the benefits of unobserved dose administration for stable opioid maintenance patients: Follow-up of a randomised trial', Drug and Alcohol Dependence, vol. 96, pp. 183 - 186, http://dx.doi.org/10.1016/j.drugalcdep.2008.02.012

Bell J; Zador D, 2007, 'Dihydrocodeine as effective as methadone for maintenance of treatment for opiate dependence? Commentary', Evidence-Based Mental Health, vol. 10, pp. 88, http://dx.doi.org/10.1136/ebmh.10.3.88

Milne B; Bell J; Lampropoulos B; Towns S, 2007, 'Alcohol, drugs and Australian young people', International Journal of Adolescent Medicine and Health, vol. 19, pp. 245 - 253, http://dx.doi.org/10.1515/IJAMH.2007.19.3.245

Bell J; Burrell T, 2006, 'Retention and attendance with supervised buprenorphine treatment: A case-note review', Drug and Alcohol Review, vol. 25, pp. 161 - 165, http://dx.doi.org/10.1080/09595230500537647

Bell J; Mutch C, 2006, 'Treatment retention in adolescent patients treated with methadone or buprenorphine for opioid dependence: A file review', Drug and Alcohol Review, vol. 25, pp. 167 - 171, http://dx.doi.org/10.1080/09595230500537670

Digiusto EA; Shakeshaft AP; Ritter A; Mattick RP; White J; Lintzeris N; Bell JR; Saunders J, 2006, 'Effects of pharmacotherapies for opioid dependence on participants` criminal behaviour and expenditure on illicit drugs: An Australian National Evaluation (NEPOD)', Australian and New Zealand Journal of Criminology, vol. 39, pp. 171 - 189, http://dx.doi.org/10.1375/acri.39.2.171

Morley K; Teesson M; Reid SC; Sannibale C; Thomson CL; Phung N; Weltman MD; Bell JR; Richardson K; Haber PS, 2006, 'Naltrexone versus acamprosate in the treatment of alcohol dependence: a multi-centre, randomized, double-blind, placebo-controlled trial', Addiction, vol. 101, pp. 1451 - 1462, http://dx.doi.org/10.1111/j.1360-0443.2006.01555.x

Shanahan MD; Doran CM; Digiusto EA; Bell JR; Lintzerisa N; White J; Ali RL; Saunders JB; Mattick RP; Gilmour S, 2006, 'A cost-effectiveness analysis of heroin detoxification methods in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD)', Addictive Behaviors, vol. 31, pp. 371 - 387, http://dx.doi.org/10.1016/j.addbeh.2005.05.016

Dean AJ; Bell J; Christie MJ; Mattick RP, 2005, 'Síntomas depresivos durante el mantenimiento con buprenorfina frente a metadona: hallazgos de un ensayo controlado distribuido al azar en la dependencia de opioides', European psychiatry (Ed. Española), vol. 12, pp. 185 - 191, http://dx.doi.org/10.1017/s1134066500003441

Bell JR; Byron G; Morris A; Gibson AE, 2004, 'A Pilot study of buprenorphine-naloxone comgination tablet (Suboxone) in treatment of opioid dependence', Drug and Alcohol Review, vol. 23, pp. 311 - 317

Dean A; Bell JR; Christie MJ; Mattick RP, 2004, 'Depressive symptoms during buprenorphine vs. methadone maintenance: findings from a randomised, controlled trial in opioid dependence', European Psychiatry, vol. 19, pp. 510 - 513, http://dx.doi.org/10.1016/j.eurpsy.2004.09.002

Rae F; Bell JR; Young MR; Mattick RP, 2004, 'A randomised, controlled trial of low dose naltrexone for the treatment of opioid dependence', Drug and Alcohol Dependence, vol. 75, pp. 79 - 88, http://dx.doi.org/10.1016/j.drugalcdep.2004.02.003

Breen CL; Harris S; Lintzeris N; Mattick RP; Hawken L; Bell JR; Ritter A; Lenne M; Mendoza E, 2003, 'Cessation of methadone maintenance treatment using uprenorphine: transfer from methadone to buprenorphine and subsequent buprenorphine reductions', Drug and Alcohol Dependence, vol. 71, pp. 49 - 55, http://dx.doi.org/10.1016/S0376-8716(03)00071-1

Doran CM; Shanahan M; Mattick RP; Ali R; White J; Bell J, 2003, 'Buprenorphine versus methadone maintenance: A cost-effectiveness analysis', Drug and Alcohol Dependence, vol. 71, pp. 295 - 302, http://dx.doi.org/10.1016/S0376-8716(03)00169-8

Doran CM; Shanahan MD; Mattick RP; Ali RL; Bell JR; White J, 2003, 'Burprenorphine verus methadone maintenance: a cost-effectiveness analysis', Drug and Alcohol Dependence, vol. 71, pp. 295 - 302

Gibson AE; Doran CM; Bell GA; Ryan A; Lintzeris N, 2003, 'A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial', Medical Journal of Australia, vol. 179, pp. 38 - 42

Gibson AE; Doran CM; Bell JR; Ryan A; Lintzeris N, 2003, 'A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial', Medical Journal of Australia, vol. 179, pp. 38 - 42

Lintzeris N; Bell J; Bammer G; Jolley DJ; Rushworth L, 2002, 'A randomized controlled trial of buprenorphine in the management of short-term ambulatory heroin withdrawal', Addiction, vol. 97, pp. 1395 - 1404, http://dx.doi.org/10.1046/j.1360-0443.2002.00215.x

Glasgow N; Taylor JW; Young MR; Bell JR; Bammer G, 2001, 'Accelerated withdrawal from methadone maintenance therapy using naltrexone and minimal sedation: a case series analysis', Drug and Alcohol Review, vol. 20, pp. 213 - 222

Nilssen O; Parker GB; Hadzi-Pavlovic D; Bell JR, 2001, 'Assessing depression in drug- and alcohol- dependent subjects: The utility of a cognitive-based approach', Nordic Journal of Psychiatry, vol. 55, pp. 409 - 412, http://dx.doi.org/10.1080/08039480152693309

Bell J, 2000, 'Quality improvement for methadone maintenance treatment.', Subst Use Misuse, vol. 35, pp. 1735 - 1756, http://dx.doi.org/10.3109/10826080009148239

Bell JR, 2000, 'Quality Assurance in Methadone Maintenance Treatment', Substance Use and Misuse, pp. 1735 - 1756

Bell JR; Zador D, 2000, 'A Risk-Benefit analysis of methadone maintenance treatment', Drug Safety, pp. 179 - 188

Bell JR, 1999, 'First, do no harm: naltrexone‐accelerated detoxification', Medical Journal of Australia, vol. 171, pp. 499 - 499, http://dx.doi.org/10.5694/j.1326-5377.1999.tb123761.x

Bell JR; Young MO; Masterman SC; Mattick RP; Bammer G, 1999, 'A pilot study of naltrexone-accelerated detoxification in opioid dependence', Medical Journal of Australia, vol. 171, pp. 26 - 30

Bell JR; Young MO; Masterman SC; Morris A; Mattick RP; Bammer G, 1999, 'A Pilot Study of Naltrexone-Accelerated Detoxification in Opoid Dependence', Medical Journal of Australia, vol. 171, pp. 26 - 30

Bell JR; Young MO; Masterman SC; Morris A; Mattick RP; Bammer G, 1999, 'A pilot study of naltrexone-accelerated detoxification in opioid dependence', Medical Journal of Australia, vol. 171, pp. 26 - 30

McKetin R; Ward PB; Catts SV; Mattick RP; Bell JR, 1999, 'Changes in auditory selective attention and event-related potentials following oral administration of D-amphetamine in humans', Neuropsychopharmacology, vol. 21, pp. 380 - 390, http://dx.doi.org/10.1016/S0893-133X(99)00017-2

Cadman M; Bell J, 1998, 'Doctors detected self-administering opioids in New South Wales, 1985-1994: Characteristics and outcomes', Medical Journal of Australia, vol. 169, pp. 419 - 421, http://dx.doi.org/10.5694/j.1326-5377.1998.tb126832.x

Chan JS; Kuk A; Bell JR; Mcgilchrist CA, 1998, 'The analysis of methadone clinic data using marginal and conditional logistic models with mixture or random effects', Australian and New Zealand Journal of Statistics, vol. 40, pp. 1 - 10, http://dx.doi.org/10.1111/1467-842X.00001

Bell JR, 1997, 'Australian trends in opioid prescribing for chronic, non-cancer pain.', Medical Journal of Australia, pp. 26 - 29

Bell JR; Mattick RP; Hay A; Chan KL; Hall WD, 1997, 'Methadone maintenance and drug-related crime', Journal of Substance Abuse, vol. 9, pp. 15 - 25, http://dx.doi.org/10.1016/S0899-3289(97)90003-1

Chan JS; Kuk A; Bell JR, 1997, 'A likelihood approach to analysing longitudinal bivariate binary data', Biometrical Journal, vol. 39, pp. 409 - 421, http://dx.doi.org/10.1002/bimj.4710390403

Bell J, 1996, 'Alternatives to non-clinical regulation: Training doctors to deliver methadone maintenance treatment', Addiction Research and Theory, vol. 3, pp. 315 - 322, http://dx.doi.org/10.3109/16066359609005245

Ward JW; Bell JR; Mattick P; Hall WD, 1996, 'Methadone maintenance therapy for opioid dependence: a guide to appropriate use', CNS Drugs, vol. 6, pp. 440 - 449, http://dx.doi.org/10.2165/00023210-199606060-00004

Bell JR, 1995, 'Lessons from a training program for methadone prescribers', Medical Journal of Australia, vol. 162, pp. 143 - 144, http://dx.doi.org/10.5694/j.1326-5377.1995.tb138479.x

Bell JR; Chan KL; Kuk A, 1995, 'Investigating the influence of treatment of philosophy on the outcome of methadone maintenance', Addiction, vol. 90, pp. 823 - 830, http://dx.doi.org/10.1046/j.1360-0443.1995.90682310.x

Howard K; Bell J; Christie MJ, 1995, 'Measuring heroin use in methadone maintenance programmes', Drug and Alcohol Review, vol. 14, pp. 27 - 34, http://dx.doi.org/10.1080/09595239500185031

BELL J; CAPLEHORN JRM; McNEIL DR, 1994, 'The effect of intake procedures on performance in methadone maintenance', Addiction, vol. 89, pp. 463 - 471, http://dx.doi.org/10.1111/j.1360-0443.1994.tb00927.x

CAPLEHORN JRM; BELL J; KLEINBAUM DG; GEBSKI VJ, 1993, 'Methadone dose and heroin use during maintenance treatment', Addiction, vol. 88, pp. 119 - 124, http://dx.doi.org/10.1111/j.1360-0443.1993.tb02769.x

Caplehorn JRM; Bell J, 1993, 'Correction of error: Methadone dosage and retention of patients in maintenance treatment [16]', Medical Journal of Australia, vol. 159, pp. 640, http://dx.doi.org/10.5694/j.1326-5377.1993.tb138072.x

Hall W; Bell J; Carless J, 1993, 'Crime and drug use among applicants for methadone maintenance', Drug and Alcohol Dependence, vol. 31, pp. 123 - 129, http://dx.doi.org/10.1016/0376-8716(93)90064-W

Robertson M; Bell J, 1993, 'Are rapid inpatient benzodiazepine detoxifications unsafe? [16]', Medical Journal of Australia, vol. 158, pp. 578 - 579, http://dx.doi.org/10.5694/j.1326-5377.1993.tb121899.x

BELL J, 1992, 'Treatment dependence: preliminary description of yet another syndrome', British Journal of Addiction, vol. 87, pp. 1049 - 1054, http://dx.doi.org/10.1111/j.1360-0443.1992.tb03123.x

BELL J; DIGIUSTO E; BYTH K, 1992, 'Who should receive methadone maintenance?', British Journal of Addiction, vol. 87, pp. 689 - 694, http://dx.doi.org/10.1111/j.1360-0443.1992.tb02714.x

BELL J; HALL W; BYTH K, 1992, 'Changes in criminal activity after entering methadone maintenance', British Journal of Addiction, vol. 87, pp. 251 - 258, http://dx.doi.org/10.1111/j.1360-0443.1992.tb02699.x

Bell J; Batey RG, 1992, 'Medicine and the addictions.', Australian and New Zealand journal of medicine, vol. 22, pp. 202 - 203, http://dx.doi.org/10.1111/j.1445-5994.1992.tb02813.x

BELL J, 1991, 'Pain and addiction', Drug and Alcohol Review, vol. 10, pp. 247 - 252, http://dx.doi.org/10.1080/09595239100185281

Caplehorn J; Bell J, 1991, 'Methadone dosage and retention of patients in maintenance treatment: In Reply', Medical Journal of Australia, vol. 155, pp. 60 - 61, http://dx.doi.org/10.5694/j.1326-5377.1991.tb116405.x

Caplehorn JRM; Bell J, 1991, 'Methadone dosage and retention of patients in maintenance treatment', Medical Journal of Australia, vol. 154, pp. 195 - 199, http://dx.doi.org/10.5694/j.1326-5377.1991.tb121030.x

White A; Foy A; Caplehorn J; Bell J, 1991, 'Methadone dosage and retention of patients in maintenance treatment [6]', Medical Journal of Australia, vol. 155, pp. 60 - 61, http://dx.doi.org/10.5694/j.1326-5377.1991.tb116404.x

BELL J; BOWRON P; LEWIS J; BATEY R, 1990, 'Serum levels of methadone in maintenance clients who persist in illicit drug use', British Journal of Addiction, vol. 85, pp. 1599 - 1602, http://dx.doi.org/10.1111/j.1360-0443.1990.tb01648.x

Bell J, 1990, 'Heroin users seeking methadone treatment (I: Reply)', Medical Journal of Australia, vol. 153, pp. 305, http://dx.doi.org/10.5694/j.1326-5377.1990.tb136926.x

Bell J; Batey RG; Farrell GC; Crewe EB; Cunningham AL; Byth K, 1990, 'Hepatitis C virus in intravenous drug users', Medical Journal of Australia, vol. 153, pp. 274 - 276, http://dx.doi.org/10.5694/j.1326-5377.1990.tb136900.x

Bell J; Fernandes D; Batey R, 1990, 'Heroin users seeking methadone treatment', Medical Journal of Australia, vol. 152, pp. 361 - 364, http://dx.doi.org/10.5694/j.1326-5377.1990.tb125185.x

Tapsall JW; Phillips EA; Cossins YM; Bates JR; MacRae J; Macleod C; Mallon R; Bieri C; Raby J; Bell J; Forsyth JRL; Peel MM; Handke G; Lumb R; Blums M; Ismail A; Nicholson G; Tucker R; Gardam M, 1990, 'Use of a quality assurance scheme in a long-term multicentric study of antibiotic susceptibility of Neisseria gonorrhoeae', Genitourinary Medicine, vol. 66, pp. 8 - 13, http://dx.doi.org/10.1136/sti.66.1.8

Bell J; Cumming R, 1989, 'Drinking habits in Sydney's western suburbs', Australian Drug and Alcohol Review, vol. 8, pp. 9 - 13, http://dx.doi.org/10.1080/09595238980000031

DWYER D; BELL J; BATEY R; SANDERS F; PATTERSON T; HOWARD R; DOWNIE J; PACKHAM DR; CUNNINGHAM AL, 1989, 'LOW PREVALENCE OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN METHADONE PROGRAM ATTENDERS AND PREGNANT INTRAVENOUS DRUG USERS IN THE WESTERN METROPOLITAN REGION OF SYDNEY', Australian and New Zealand Journal of Medicine, vol. 19, pp. 407 - 408, http://dx.doi.org/10.1111/j.1445-5994.1989.tb00288.x

Bell J; Seres V; Bowron P; Lewis J; Batey R, 1988, 'The use of serum methadone levels in patients receiving methadone maintenance', Clinical Pharmacology and Therapeutics, vol. 43, pp. 623 - 629, http://dx.doi.org/10.1038/clpt.1988.86

Bell J; The E; Patel A; Lewis J; Batey R, 1988, 'The detection of at-risk drinking in a teaching hospital', Medical Journal of Australia, vol. 149, pp. 351 - 355, http://dx.doi.org/10.5694/j.1326-5377.1988.tb120666.x

Tapsall JW; Phillips EA; Cossins YM; Gray BR; Mallon R; Macrae J; Macleod C; Raby J; Bell J; Forsyth JRL; Peel MM; Handke G; Blums M; Ismail A; Tucker R; Gardam M; Way B; Tozer R; Withnall K, 1988, 'Penicillin sensitivity of gonococci isolated in Australia, 1981-6', Genitourinary Medicine, vol. 64, pp. 147 - 151

Tapsall JW; Phillips EA; Morris LM; Cossins YM; Bates JR; Macleod C; Mallon R; Macrae JA; Raby J; Bell J; Forsyth JRI; Peel MM; Tucker R; Gardam M; Handke GC; Blums M; Ismail A; Way B; Withnall KM, 1988, 'Changing patterns in gonococcal infection in Australia, 1981-1987', Medical Journal of Australia, vol. 149, pp. 609 - 612, http://dx.doi.org/10.5694/j.1326-5377.1988.tb120801.x

Larance B; Degenhardt L; Mattick R; Bell J; Winstock A, 2009, 'CHARACTERISTICS OF THE ILLICIT MARKET FOR THE PHARMACEUTICAL OPIOIDS USED IN OPIOID SUBSTITUTION TREATMENT IN AUSTRALIA', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL PUBLISHING, INC, pp. A36 - A37, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270916300110&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bell J; Dru A; Fischer B; Levit S; Sarfraz MA, 2002, 'Substitution therapy for heroin addiction', in Substance Use and Misuse, pp. 1149 - 1178, http://dx.doi.org/10.1081/JA-120004176